Expert Consulting for Efficient Clinical Trial Execution

Accelerate Your Clinical Trials Today

Expert Consulting for Efficient Clinical Trial Execution

Accelerate Your Clinical Trials Today

Expert Consulting for Efficient Clinical Trial Execution

Accelerate Your Clinical Trials Today

Trusted by Medtech Startups
Trusted by Medtech Startups

Streamlining clinical development from first-in-human to real-world evidence.

We deliver high-impact, ethically sound, and scientifically credible clinical evidence for innovative medical technologies. Let’s turn your clinical vision into reality - on time and on budget.

Building long-term partnerships to accelerate clinical success.

We work closely with your team to design and execute impactful clinical development strategies - leveraging deep expertise, trusted relationships, and a shared commitment to success.

“We are committed to delivering precise, well-researched clinical guidance that empowers medtech startups and healthcare innovators to design and execute efficient, scientifically sound programs - driving regulatory approvals and successful commercialization.”

“We are committed to delivering precise, well-researched clinical guidance that empowers medtech startups and healthcare innovators to design and execute efficient, scientifically sound programs - driving regulatory approvals and successful commercialization.”
Anna K. Gawlicka, PhD, MBA

Anna K. Gawlicka, PhD, MBA

President & Chief Clinical Officer,

President & Chief Clinical Officer,

Innovative Clinical Strategies, LLC

Innovative Clinical Strategies, LLC

Helping medtech startups bring innovations to market

Putting the right solutions and methods in place.

Early-stage development

01

Pivotal trials & global expansion

02

Trial start-up & execution

03

Trial oversight & quality assurance

04

Regulatory & market support

05

Early-stage development

Transforming bold ideas into viable clinical plans.

Helping medtech startups bring innovations to market

Putting the right solutions and methods in place.

Early-stage development

01

Pivotal trials & global expansion

02

Trial start-up & execution

03

Trial oversight & quality assurance

04

Regulatory & market support

05

Early-stage development

Transforming bold ideas into viable clinical plans.

Helping medtech startups bring innovations to market

Putting the right solutions and methods in place.

Early-stage development

01

Pivotal trials & global expansion

02

Trial start-up & execution

03

Trial oversight & quality assurance

04

Regulatory & market support

05

Early-stage development

Transforming bold ideas into viable clinical plans.

Clinical expertise from strategies to publications

Whether you’re launching a first-in-human trial or scaling a post-market registry, we tailor our approach to meet your unique goals.

Aligned with objectives for market expansions, read regulatory approvals & reimbursement positioning

Addressing all stakeholders’ needs

Supporting clinical effectiveness & safety

Maximizing trial success

Planning: protocol, budget, timeline

Development: IRB/IEC approval, site contract negotiations

Execution: enrollment, monitoring

Closure: data collection & analysis

Trial management per project management

CRO management

Clinical QC & QA

Biostatistical programming & analysis

Sensitivity analysis

Cost-effectiveness analysis

Survey design & analysis

Strategy development

Manuscript preparation, submission & revision

Preparation of clinical sections & ISS/ISE for regulatory submissions

Publications

Data Analytics

Clinical Trials

Clinical Strategies

Aligned with objectives for market expansions, read regulatory approvals & reimbursement positioning

Addressing all stakeholders’ needs

Supporting clinical effectiveness & safety

Maximizing trial success

Planning: protocol, budget, timeline

Development: IRB/IEC approval, site contract negotiations

Execution: enrollment, monitoring

Closure: data collection & analysis

Trial management per project management

CRO management

Clinical QC & QA

Biostatistical programming & analysis

Sensitivity analysis

Cost-effectiveness analysis

Survey design & analysis

Strategy development

Manuscript preparation, submission & revision

Preparation of clinical sections & ISS/ISE for regulatory submissions

Publications

Data Analytics

Clinical Trials

Clinical Strategies

Aligned with objectives for market expansions, regulation approvals & reimbursement positioning

Addressing all stakeholders’ needs

Supporting clinical effectiveness & safety

Maximizing trial success

Planning: protocol, budget, timeline

Development: IRB/IEC approval, site contract negotiations

Execution: enrollment, monitoring

Closure: data collection & analysis

Trial management per project management

CRO management

Clinical QC & QA

Clinical Trials

Clinical Strategies

Biostatistical programming & analysis

Sensitivity analysis

Cost-effectiveness analysis

Survey design & analysis

Data Analytics

Publications

Strategy development

Manuscript preparation, submission & revision

Preparation of clinical sections & ISS/ISE for regulatory submissions

Track record of successful trials

15

Feasibility trials
Community
members

19

Pivotal trials

20

Postmarket surveillance
  • “I’ve worked with Anna on several projects over more than a decade, advancing ENT medical innovations from concept to widespread clinical application. She brings sharp insight unwavering integrity, and a rare ability to turn complex challenges into successful clinical outcomes. I can’t think of anyone more capable.”

    Simon Wright, MD, PhD,  FACS

    Physician/Professor of Surgeon, Iowa ENT Center

  • “Anna’s clinical insight, leadership, and collaborative spirit were pivotal in driving our efforts toward successful regulatory approvals and impactful publications. It was truly a pleasure collaborating with Anna, and I look forward to seeing the positive impact she’ll continue to make in the field.”

    J. Pablo Stolovitzky, MD

    CEO, ENT of Georgia. Clinical Faculty, Emory University School of Medicine

  • “I had the pleasure of working with Anna on several breakthrough clinical programs, including EsophyX, and GT Metabolic Magnetic Anastomosis System. Anna brings a rare combination of energy, can do attitude, clinical insight, executional discipline, and strategic thinking—she played a pivotal role in shaping the clinical path for these technologies in the start-up environment”

    Thierry B. Thaure

    CEO, GT Metabolic Solutions

  • “Anna brings exceptional expertise in clinical trial design across multiple therapeutic areas, paired with a sharp sense of business strategy—a rare and powerful combination. Beyond her impressive credentials, she has a unique talent for building and inspiring high-performing teams. Anyone who has worked with Anna would gladly do so again.”

    James E. Kallman, MD, FACS

    Head-Neck Surgeon & Medical Advisor

  • “I’ve worked with Anna on several projects over more than a decade, advancing ENT medical innovations from concept to widespread clinical application. She brings sharp insight unwavering integrity, and a rare ability to turn complex challenges into successful clinical outcomes. I can’t think of anyone more capable.”

    Simon Wright, MD, PhD,  FACS

    Physician/Professor of Surgeon, Iowa ENT Center

  • “Anna’s clinical insight, leadership, and collaborative spirit were pivotal in driving our efforts toward successful regulatory approvals and impactful publications. It was truly a pleasure collaborating with Anna, and I look forward to seeing the positive impact she’ll continue to make in the field.”

    J. Pablo Stolovitzky, MD

    CEO, ENT of Georgia. Clinical Faculty, Emory University School of Medicine

  • “I had the pleasure of working with Anna on several breakthrough clinical programs, including EsophyX, and GT Metabolic Magnetic Anastomosis System. Anna brings a rare combination of energy, can do attitude, clinical insight, executional discipline, and strategic thinking—she played a pivotal role in shaping the clinical path for these technologies in the start-up environment”

    Thierry B. Thaure

    CEO, GT Metabolic Solutions

  • “Anna brings exceptional expertise in clinical trial design across multiple therapeutic areas, paired with a sharp sense of business strategy—a rare and powerful combination. Beyond her impressive credentials, she has a unique talent for building and inspiring high-performing teams. Anyone who has worked with Anna would gladly do so again.”

    James E. Kallman, MD, FACS

    Head-Neck Surgeon & Medical Advisor